ensuring knowledge, enhancing quality
A 'not-for-profit' organisation, run for pharmaceutical analysts by pharmaceutical analysts

Wednesday 31st August 2011
Measurement for the control of continuous processes
The last decade has seen some of the most challenging technical changes the
industry has ever experienced arising from the introduction of PAT; Risk
Management; QbD and the transition from Validation to Continuous Verification.
These changes, deigned to bring significantly improved performance through enhanced process control, will impact holistically on all aspects of operations across research, development and manufacture.

This seminar examines how innovative applications of measurement sciences are
pivotal to the implementation of the transition from batch to continuous processing, to deliver the full benefit of these changes as a key aspect of “The Science of Medicines”.

Session 1:
11.00 - 11.30 The drivers for a new business model
Dr Steve Wicks, University of Greenwich
11.30 - 12.00 Continuous verification for APIs
Dr Ian Clegg, Pfizer
12.00 - 12.30 Short papers

Session 2:
14.30 - 15.00 The change that control of continuous processes offers for particle engineering
Dr Richard Storey, AstraZeneca
15.00 - 15.30 The role PAT plays in defining critical processing parameters in legacy product manufacture
Dr Sander van den Ban, GSK
15.30 - 16.00 Short papers

Session 3:
16.30 - 17.00 Short papers
17.00 - 17.30 The new process validation guidance; defining meaningful measurement and sampling strategies to implement process control using continuous verification
Dr Jon Clark. FDA (via video conferencing)
17.30 - 18.00 The compliance revolution; the impact on the QP
Dr Dave Rudd, GSK



You will have access to materials for meetings that you have attended.

You will need to Sign In to activate access to your additional options.
Once Signed in, click on RESOURCES and look under MY PAST MEETINGS.

Symposium - October 2011

Delegates at a symposium held at the Royal Pharmaceutical Society

Joint Pharmaceutical Analysis Group 2023
Website © and by Delta Consultancy Services